Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
04 February 2025 - 8:57AM
Edgar (US Regulatory)
NYC#: 139632.2
Exhibit A
Joint Filing Agreement
The undersigned hereby agree that this Statement on Schedule 13G/A with respect to the beneficial ownership of shares of Common Stock of Cellectar Biosciences, Inc. is filed jointly, on behalf of each of them.
Rosalind Advisors, Inc.
By: _____________________________
Name: Steven Salamon
Title: President
Rosalind Master Fund L.P.
By: _____________________________
Name: Mike McDonald
Title: Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
By: _____________________________
Name: Steven Salamon
Rosalind Opportunities Fund I L.P.
By: _____________________________
Name: Steven Salamon
Title: Director, Rosalind Opportunities Fund I GP. Inc. (as General Partners to Rosalind Opportunities Fund I)
NYC#: 139632.2
Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Feb 2025 to Mar 2025
Cellectar Biosciences (NASDAQ:CLRB)
Historical Stock Chart
From Mar 2024 to Mar 2025